AM
Charitable Trust was formed in March 1998 to explore the possibility
of solutions to cancer using combination therapies (complementary
therapies in combination with conventional therapies such as chemotherapy,
radiotherapy and surgery as adjuvant therapies) or a combination
of alternative therapies only.
The Vision
The Vision of the Trust is to validate one or more of the Complementary
systems of therapy for cancer, prove that a permanent cure for
cancer exists and evolve the treatment to perfection and to prevent
occurrence of cancer through recognized prevention approaches.
The
Mission
The Mission of the Trust is to set up the necessary programme
of experimentation and investigations in the Complementary Systems
of cancer therapy particularly Yoga including Yoga-Nidra, Chidakasa
Dharana and Pranic Healing, Ayurveda, Homeopathy and Siddha systems
of medicine as also nutritional aspects, Meditation and undertake
an extensive research project with controlled protocols and validate
these systems conclusively. To campaign for improving awareness
of occurrence of cancer & enable people to prevent it.
Objectives
- Give
assurance to cancer patients that even advanced stages of
cancer need not lead to certain death.
- To minimise
the pain and suffering of cancer patients that is caused due
to chemotherapy / radiotherapy.
- To improve
the quality of life of cancer patients through Complementary
scientific approaches.
- To identify
the factors that lead to cure in the so-called 'random occurrences'
of cancer cure.
- To popularise
dietary and nutrition related approaches to prevent Cancer
as also to reduce its impact.
- To scientifically
validate the Complementary Therapies using the most modern
and advanced testing techniques.
- To campaign
for and to carry out programmes for early detection of cancer
in order to improve the survival rate for cancer patients.
- To identify
and disseminate information on preventive measures for cancer.
ex:- dietary and life style management.
- To undertake
extensive Cancer awareness camps.